ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.05
-0.15 (-0.78%)
May 9, 2025, 1:35 PM CST

ScinoPharm Taiwan Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
3,0984,1663,9424,2954,0814,055
Upgrade
Cash & Short-Term Investments
3,0984,1663,9424,2954,0814,055
Upgrade
Cash Growth
-26.70%5.70%-8.22%5.24%0.64%16.61%
Upgrade
Accounts Receivable
446.6604.22788.22635.26360.25386.51
Upgrade
Other Receivables
29.0620.5725.2318.2832.886.43
Upgrade
Receivables
475.66624.79813.45653.55393.04472.93
Upgrade
Inventory
1,7921,6731,5121,1891,3451,246
Upgrade
Prepaid Expenses
170.57114.91105.79132.2496.85108.08
Upgrade
Other Current Assets
-29.48.351.1350.7134.31
Upgrade
Total Current Assets
5,5366,6086,3816,3205,9675,916
Upgrade
Property, Plant & Equipment
4,3514,4264,3994,4984,6484,841
Upgrade
Long-Term Investments
1,30970.1369.97112.62185.8308.12
Upgrade
Other Intangible Assets
16.6617.1319.159.958.798.9
Upgrade
Long-Term Deferred Tax Assets
638.64625.26640.93637.44614.98602.98
Upgrade
Other Long-Term Assets
207.73196.6211.48332.96267.07170
Upgrade
Total Assets
12,06011,94311,72211,91111,69111,847
Upgrade
Accounts Payable
150.6882.17102.46126.570.86160.84
Upgrade
Accrued Expenses
-143.45139.78139.6124.62125.97
Upgrade
Short-Term Debt
51.9735.5632.1477.6-9.49
Upgrade
Current Portion of Leases
23.819.6417.5617.8916.1716.5
Upgrade
Current Income Taxes Payable
32.3211.562.699.6471.1767.97
Upgrade
Current Unearned Revenue
111.14119.4110.9767.7570.5766.85
Upgrade
Other Current Liabilities
365.42355.97263.96274.12202.93239.02
Upgrade
Total Current Liabilities
735.32767.68729.45803.09556.31686.65
Upgrade
Long-Term Leases
620.95620.34570.23581.18540.27550.18
Upgrade
Long-Term Deferred Tax Liabilities
2.041.31.66-0.35-
Upgrade
Other Long-Term Liabilities
16.293.991.32.363.651.3
Upgrade
Total Liabilities
1,3751,4171,3571,4611,1801,317
Upgrade
Common Stock
7,9077,9077,9077,9077,9077,907
Upgrade
Additional Paid-In Capital
1,2951,2951,2951,2951,2951,295
Upgrade
Retained Earnings
1,4961,4501,3481,3461,3701,360
Upgrade
Comprehensive Income & Other
-12.94-126.18-185.86-98.18-61.13-33.04
Upgrade
Shareholders' Equity
10,68510,52610,36410,45010,51110,529
Upgrade
Total Liabilities & Equity
12,06011,94311,72211,91111,69111,847
Upgrade
Total Debt
696.72675.54619.92676.67556.43576.18
Upgrade
Net Cash (Debt)
2,4013,4903,3223,6183,5243,479
Upgrade
Net Cash Growth
-32.53%5.08%-8.19%2.65%1.31%31.91%
Upgrade
Net Cash Per Share
3.044.404.194.564.454.39
Upgrade
Filing Date Shares Outstanding
767.05790.74790.74790.74790.74790.74
Upgrade
Total Common Shares Outstanding
767.05790.74790.74790.74790.74790.74
Upgrade
Working Capital
4,8015,8405,6515,5175,4105,229
Upgrade
Book Value Per Share
13.9313.3113.1113.2213.2913.32
Upgrade
Tangible Book Value
10,66810,50910,34510,44010,50210,521
Upgrade
Tangible Book Value Per Share
13.9113.2913.0813.2013.2813.30
Upgrade
Buildings
-4,3094,2494,0953,5463,518
Upgrade
Machinery
-6,6476,4326,2495,6415,598
Upgrade
Construction In Progress
-194.0477.72155.621,1191,052
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.